Reduction of natural killer and natural killer T cells is not protective in cisplatin-induced acute renal failure in mice

Nephrology

Volumn 16, Issue 6, 2011, Pages 545-551

  Kim, Hye Ryoun ^a   Lee, Mi Kyung ^a   Park, Ae Ja ^a   Park, Eon Seob ^a   Kim, Dong Seok ^a   Ahn, Jihyun ^a   Kim, Jaetack ^a   Kim, Su Hyun ^a   Oh, Dong Jin ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

acute kidney injury; cisplatin; killer cells; natural

Indexed keywords

ALPHA2 INTEGRIN; CISPLATIN; FRACTALKINE; GRANZYME A; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NK1.1; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL INFILTRATION; CISPLATIN INDUCED ACUTE KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJURY SCALE; KIDNEY; KIDNEY FUNCTION; KILLER CELL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T CELL DEPLETION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, LY; APOPTOSIS; CASPASE 1; CHEMOKINE CX3CL1; CHEMOTAXIS, LEUKOCYTE; CISPLATIN; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GRANZYMES; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; TIME FACTORS;

EID: 80051683285     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01473.x     Document Type: Article

References (24)

1. Edelstein CL, Schrier RW,. Pathophysiology of ischemic acute renal injury. In:, Schrier RW, (ed.), 7th edn. Diseases of the Kidney and Urinary Tract. Philadelphia, PA: Lippincott Williams & Wilkins, 2011; 930-61.
2. Safirstein RL,. Renal disease induced by anti-neoplastic agents. In:, Schrier RW, (ed.), 8th edn. Diseases of the Kidney and Urinary Tract. Philadelphia, PA: Lippincott Williams & Wilkins, 2006; 1068-81.
3. Bonventre JV, Zuk A,. Ischemic acute renal failure: An inflammatory disease? Kidney Int. 2004; 66 (2): 480-5. (Pubitemid 38981982)
4. Friedewald JJ, Rabb H,. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004; 66 (2): 486-91. (Pubitemid 38981983)
5. Devarajan P,. Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 2006; 17 (6): 1503-20. (Pubitemid 43841396)
6. Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV,. Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int. 1999; 56 (3): 922-31. (Pubitemid 29411719)
7. Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edelstein CL,. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int. 2004; 66 (6): 2202-13. (Pubitemid 41115283)
8. Lu LH, Oh DJ, Dursun B, et al,. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 2008; 324: 111-17. (Pubitemid 350294166)
9. Faubel S, Lewis EC, Reznikov L, et al,. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007; 322 (1): 8-15. (Pubitemid 46956357)
10. Umehara H, Goda S, Imai T, et al,. Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immune. Cell Biol. 2001; 79: 298-302. (Pubitemid 32522179)
11. Cerwenka A, Lanier LL,. Natural killer cells, viruses, and cancer. Nat. Rev. Immunol. 2001; 1: 41-9. (Pubitemid 33741974)
12. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ,. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am. J. Physiol. Renal Physiol. 2002; 282 (2): F352-7. (Pubitemid 34654567)
13. Tadagavadi RK, Reeves WB,. Endogenous IL-10 attenuates cisplatin nephrotoxicity: Role of dendritic cells. J. Immunol. 2010; 175: 4904-11.
14. Lee HJ, Nho DH, Chung HS, et al,. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. 2010; 78: 1100-9.
15. Caroll JL, Nielsen LL, Pruett SB, Mathis JM,. The role of natural killer cells in adenovirus-mediated p53 gene therapy. Mol. Cancer Ther. 2001; 1: 49-60.
16. Mühlen KA, Schümann J, Wittke F, et al,. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J. Immunol. 2004; 172 (5): 3034-41. (Pubitemid 38263692)
17. Dursun B, He Z, Somerset H, Oh DJ, Faubel S, Edelstein CL,. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am. J. Physiol. Renal Physiol. 2006; 291 (3): F578-87. (Pubitemid 44343739)
18. Shi Y, Melnikov VY, Schrier RW, Edelstein CL,. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am. J. Physiol. Renal Physiol. 2000; 279 (3): F509-17.
19. Feng L, Chen S, Garcia GE, et al,. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int. 1999; 56 (2): 612-20. (Pubitemid 29353159)
20. Oh DJ, Dursun B, He Z, et al,. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am. J. Physiol. Renal Physiol. 2008; 294 (1): F264-71.
21. Simon MM, Hausmann M, Tran T, et al,. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 1997; 186: 1781-6. (Pubitemid 27506292)
22. Liu M, Chien CC, Burne-Taney M, et al,. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J. Am. Soc. Nephrol. 2006; 17 (3): 765-74.
23. Ramesh G, Reeves WB,. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am. J. Physiol. Renal Physiol. 2005; 289 (1): F166-74. (Pubitemid 40863584)
24. Zhang B, Ramesh G, Norbury CC, Reeves WB,. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int. 2007; 72 (1): 37-44. (Pubitemid 47014442)